CIK 0000315545
- Non-accelerated filer
- Smaller reporting company
PROVECTUS BIOPHARMACEUTICALS, INC.
Sign in to watch- Ticker
- PVCT
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 900031917
- Phone
- +1 866-594-5999
- Business address
- 800 S. GAY STREET, SUITE 1610, KNOXVILLE, TN, 37929
- Former names
- PROVECTUS PHARMACEUTICALS INC, PROVECTUS PHARMACEUTICAL INC, ZAMAGE DIGITAL IMAGING INC, SPM GROUP INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 53 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2009-06-08 | WACHTER ERIC PHD Vice President Pharmaceuticals | Exercise or conversion · Employee Stock Option (Right to Buy) | −109,375 | $0.64 | $70K | 105,469 |
| 2009-04-01 | WACHTER ERIC PHD Vice President Pharmaceuticals | Exercise or conversion | +46,875 | $0.64 | $30K | 2,532,640 |
| 2009-04-01 | WACHTER ERIC PHD Vice President Pharmaceuticals | Exercise or conversion · Employee Stock Option (Right to Buy) | −46,875 | 214,844 | ||
| 2008-11-20 | WACHTER ERIC PHD Vice President Pharmaceuticals | Exercise or conversion | +66,666 | $0.94 | $63K | 2,485,765 |
| 2008-11-20 | WACHTER ERIC PHD Vice President Pharmaceuticals | Exercise or conversion · Stock Options (right to buy) | −66,666 | 133,334 | ||
| 2008-06-27 | WACHTER ERIC PHD Executive VP Pharmaceuticals | Grant or award · Stock Options (right to buy) | +50,000 | 50,000 | ||
| 2008-06-27 | FUCHS STUART Director | Grant or award · Stock Options (right to buy) | +50,000 | 50,000 | ||
| 2008-06-27 | SCOTT TIMOTHY PHD President | Grant or award · Stock Options (right to buy) | +50,000 | 50,000 | ||
| 2008-06-27 | DEES H CRAIG Chief Executive Officer | Grant or award · Stock Options (right to buy) | +50,000 | $1.05 | $53K | 50,000 |
| 2008-06-24 | WACHTER ERIC PHD Executive VP Pharmaceuticals | Exercise or conversion | +30,000 | $1.02 | $31K | 2,419,099 |
| 2008-06-24 | WACHTER ERIC PHD Executive VP Pharmaceuticals | Exercise or conversion · Stock Options (right to buy) | −30,000 | 1,020,000 | ||
| 2008-06-12 | CULPEPPER PETER R Chief Financial Officer | Exercise or conversion | +44,795 | $1.10 | $49K | 260,376 |
| 2008-06-12 | CULPEPPER PETER R Chief Financial Officer | Exercise or conversion · Stock Options (Right to Buy) | −44,795 | 189,624 | ||
| 2008-06-12 | CULPEPPER PETER R Chief Financial Officer | Exercise or conversion | +44,795 | $1.10 | $49K | 110,376 |
| 2008-06-12 | CULPEPPER PETER R Chief Financial Officer | Exercise or conversion · Stock Options (Right to Buy) | −44,795 | 189,624 | ||
| 2008-06-03 | McMasters Kelly M Director | Exercise or conversion · Stock Options (Right to Buy) | +50,000 | 50,000 | ||
| 2008-06-03 | McMasters Kelly M Director | Exercise or conversion · Warrant to Purchase Common Shares | +10,000 | 10,000 | ||
| 2008-05-30 | WACHTER ERIC PHD Executive VP Pharmaceuticals | Exercise or conversion | +38,281 | $0.64 | $24K | 2,364,099 |
| 2008-05-30 | WACHTER ERIC PHD Executive VP Pharmaceuticals | Exercise or conversion | +25,000 | $0.62 | $16K | 2,389,099 |
| 2008-05-30 | WACHTER ERIC PHD Executive VP Pharmaceuticals | Exercise or conversion · Stock Options (Right to Buy) | −38,281 | 261,719 |
Page 22 of 28 · 553 trades